US 8841266
Pharmaceutical composition and method for regulating abnormal cellular proliferation
granted A61PA61P35/00
Quick answer
US patent 8841266 (Pharmaceutical composition and method for regulating abnormal cellular proliferation) held by The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer
- Grant date
- Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P35/00